Society of Dermatology Physician Associates Conference

A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.

With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.

Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.

Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.

In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"

Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.

Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.

Catch up on coverage from the first day of the 2023 SDPA Annual Summer Dermatology Conference.

Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.

Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.

Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.

Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."

When sessions, late-breaking research, and more conclude, there is no shortage of things to do in historic Boston.

Click here to answer today's poll.

The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Boston, Massachusetts.

Click here to answer this week's poll.

Catch up on coverage from the 2022 Society of Dermatology Physician Assistants Conference.

As the Society of Dermatology Physician Assistants Conference begins this week, speakers share what they’re excited about.

Robert Kirsner, MD, PhD, discusses how to heal difficult wounds at the 2022 SDPA Fall Conference.

Hilary Baldwin, MD, discusses the pathology and treatment options for acne and rosacea at the SDPA 2022 Fall Conference.

Tazarotene lotion uses polymeric emulsion technology to improve skin barrier function, according to a poster presentation at the 2022 SDPA Conference.

Andrew Alexis, MD, shares his best tips for appropriate laser use in skin of color patients at the 2022 SDPA Conference.

At the 2022 SDPA Conference, Cynthia Trickett, PA-C, MPAS talks about her 2 sessions; psoriasis primer and kodachromes.

A poster presentation from the 2022 SDPA Conference reviewed an elastic-scattering spectroscopy device for melanoma detection.

Renata Block, MMS, PA-C., explains the importance of The Society of Dermatology Physician Assistants (SDPA) 2022 Conference.